Annual Interest Expense
$1.52 B
+$657.28 M+75.88%
March 31, 2024
Summary
- As of February 7, 2025, TAK annual interest expense is $1.52 billion, with the most recent change of +$657.28 million (+75.88%) on March 31, 2024.
- During the last 3 years, TAK annual interest expense has risen by +$289.61 million (+23.47%).
- TAK annual interest expense is now at all-time high.
Performance
TAK Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$207.15 M
-$253.71 M-55.05%
December 1, 2024
Summary
- As of February 7, 2025, TAK quarterly interest expense is $207.15 million, with the most recent change of -$253.71 million (-55.05%) on December 1, 2024.
- Over the past year, TAK quarterly interest expense has dropped by -$253.71 million (-55.05%).
- TAK quarterly interest expense is now -68.10% below its all-time high of $649.27 million, reached on June 30, 2021.
Performance
TAK Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$692.95 M
-$243.69 M-26.02%
December 1, 2024
Summary
- As of February 7, 2025, TAK TTM interest expense is $692.95 million, with the most recent change of -$243.69 million (-26.02%) on December 1, 2024.
- Over the past year, TAK TTM interest expense has dropped by -$243.69 million (-26.02%).
- TAK TTM interest expense is now -62.89% below its all-time high of $1.87 billion, reached on December 31, 2020.
Performance
TAK TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
TAK Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +75.9% | -55.0% | -26.0% |
| 3 y3 years | +23.5% | +379.4% | -47.1% |
| 5 y5 years | +250.7% | +151.5% | -43.9% |
TAK Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.9% | -63.4% | +157.9% | -47.8% | at low |
| 5 y | 5-year | at high | +250.7% | -68.1% | +151.5% | -62.9% | at low |
| alltime | all time | at high | >+9999.0% | -68.1% | +151.5% | -62.9% | >+9999.0% |
Takeda Pharmaceutical Company Limited Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $207.15 M(-55.1%) | $692.95 M(-26.0%) |
| Sep 2024 | - | $460.86 M(+20.4%) | $936.64 M(+6.7%) |
| Jun 2024 | - | $382.91 M(-207.0%) | $877.47 M(-5.5%) |
| Mar 2024 | $1.52 B(+75.9%) | -$357.96 M(-179.4%) | $928.72 M(-23.4%) |
| Dec 2023 | - | $450.84 M(+12.2%) | $1.21 B(-8.7%) |
| Sep 2023 | - | $401.69 M(-7.5%) | $1.33 B(+0.9%) |
| Jun 2023 | - | $434.16 M(-685.6%) | $1.32 B(+0.5%) |
| Mar 2023 | $866.26 M(-20.6%) | -$74.13 M(-113.1%) | $1.31 B(+9.0%) |
| Dec 2022 | - | $565.67 M(+45.2%) | $1.20 B(+14.8%) |
| Sep 2022 | - | $389.47 M(-9.0%) | $1.05 B(+2.8%) |
| Jun 2022 | - | $428.09 M(-335.6%) | $1.02 B(-17.9%) |
| Mar 2022 | $1.09 B(-11.6%) | -$181.69 M(-144.2%) | $1.24 B(+21.6%) |
| Dec 2021 | - | $410.86 M(+14.0%) | $1.02 B(-15.7%) |
| Sep 2021 | - | $360.47 M(-44.5%) | $1.21 B(-16.7%) |
| Jun 2021 | - | $649.27 M(-261.5%) | $1.45 B(+17.3%) |
| Mar 2021 | $1.23 B(-10.0%) | -$402.07 M(-167.0%) | $1.24 B(-33.9%) |
| Dec 2020 | - | $600.04 M(-0.3%) | $1.87 B(+11.8%) |
| Sep 2020 | - | $601.85 M(+38.3%) | $1.67 B(+6.8%) |
| Jun 2020 | - | $435.33 M(+89.2%) | $1.56 B(+1.0%) |
| Mar 2020 | $1.37 B(+215.6%) | $230.07 M(-42.8%) | $1.55 B(+12.3%) |
| Dec 2019 | - | $402.22 M(-18.9%) | $1.38 B(+17.4%) |
| Sep 2019 | - | $496.03 M(+18.4%) | $1.17 B(+54.6%) |
| Jun 2019 | - | $419.11 M(+595.1%) | $758.71 M(+59.6%) |
| Mar 2019 | $434.39 M(+379.6%) | $60.30 M(-69.5%) | $475.24 M(+59.7%) |
| Dec 2018 | - | $197.58 M(+141.8%) | $297.55 M(+86.0%) |
| Sep 2018 | - | $81.72 M(-39.7%) | $159.98 M(+20.7%) |
| Jun 2018 | - | $135.64 M(-215.5%) | $132.52 M(+53.1%) |
| Mar 2018 | $90.58 M(+29.6%) | -$117.39 M(-295.6%) | $86.56 M(-28.4%) |
| Dec 2017 | - | $60.01 M(+10.6%) | $120.84 M(+5.3%) |
| Sep 2017 | - | $54.27 M(-39.5%) | $114.80 M(-1.6%) |
| Jun 2017 | - | $89.68 M(-207.9%) | $116.70 M(+52.0%) |
| Mar 2017 | $69.91 M(-73.7%) | -$83.11 M(-254.0%) | $76.76 M(-55.3%) |
| Dec 2016 | - | $53.96 M(-3.9%) | $171.62 M(-7.6%) |
| Sep 2016 | - | $56.17 M(+12.9%) | $185.66 M(-29.9%) |
| Jun 2016 | - | $49.74 M(+323.3%) | $264.69 M(+0.7%) |
| Mar 2016 | $266.09 M | $11.75 M(-82.7%) | $262.75 M(-10.7%) |
| Dec 2015 | - | $68.00 M(-49.7%) | $294.30 M(-13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $135.20 M(+182.8%) | $339.88 M(+28.9%) |
| Jun 2015 | - | $47.81 M(+10.4%) | $263.77 M(-12.1%) |
| Mar 2015 | $300.65 M(-2.0%) | $43.30 M(-61.9%) | $300.03 M(-20.0%) |
| Dec 2014 | - | $113.58 M(+92.2%) | $374.81 M(+16.0%) |
| Sep 2014 | - | $59.08 M(-29.7%) | $323.13 M(-3.8%) |
| Jun 2014 | - | $84.07 M(-28.8%) | $335.98 M(+10.2%) |
| Mar 2014 | $306.72 M(+23.9%) | $118.08 M(+90.8%) | $305.02 M(-20.7%) |
| Dec 2013 | - | $61.90 M(-14.0%) | $384.42 M(+16.0%) |
| Sep 2013 | - | $71.93 M(+35.4%) | $331.39 M(+23.1%) |
| Jun 2013 | - | $53.11 M(-73.1%) | $269.22 M(+19.2%) |
| Mar 2013 | $247.51 M(+937.5%) | $197.49 M(+2127.1%) | $225.85 M(+501.6%) |
| Dec 2012 | - | $8.87 M(-9.1%) | $37.54 M(+5.0%) |
| Sep 2012 | - | $9.75 M(+0.1%) | $35.77 M(+17.6%) |
| Jun 2012 | - | $9.74 M(+6.2%) | $30.41 M(+27.2%) |
| Mar 2012 | $23.86 M(+53.9%) | $9.18 M(+29.4%) | $23.92 M(+22.0%) |
| Dec 2011 | - | $7.09 M(+61.2%) | $19.61 M(+24.3%) |
| Sep 2011 | - | $4.40 M(+35.4%) | $15.77 M(+1.4%) |
| Jun 2011 | - | $3.25 M(-33.2%) | $15.55 M(-0.6%) |
| Mar 2011 | $15.50 M(+0.7%) | $4.86 M(+49.3%) | $15.63 M(+14.5%) |
| Dec 2010 | - | $3.26 M(-22.0%) | $13.66 M(-4.2%) |
| Sep 2010 | - | $4.18 M(+25.2%) | $14.26 M(-6.2%) |
| Jun 2010 | - | $3.34 M(+15.6%) | $15.21 M(-1.1%) |
| Mar 2010 | $15.40 M(-5.5%) | $2.89 M(-25.3%) | $15.38 M(-5.8%) |
| Dec 2009 | - | $3.86 M(-24.6%) | $16.34 M(+11.2%) |
| Sep 2009 | - | $5.12 M(+46.0%) | $14.69 M(-6.9%) |
| Jun 2009 | - | $3.51 M(-8.5%) | $15.79 M(+28.6%) |
| Mar 2009 | $16.30 M(+457.9%) | $3.84 M(+73.2%) | $12.27 M(+45.5%) |
| Dec 2008 | - | $2.22 M(-64.4%) | $8.44 M(+35.6%) |
| Sep 2008 | - | $6.22 M | $6.22 M |
| Mar 2008 | $2.92 M(+38.3%) | - | - |
| Mar 2007 | $2.11 M(-34.5%) | - | - |
| Mar 2006 | $3.23 M(+3.7%) | - | - |
| Mar 2005 | $3.11 M(-2.3%) | - | - |
| Mar 2004 | $3.19 M(-7.7%) | - | - |
| Mar 2003 | $3.45 M(-43.2%) | - | - |
| Mar 2002 | $6.08 M(-34.2%) | - | - |
| Mar 2001 | $9.24 M(-14.1%) | - | - |
| Mar 2000 | $10.77 M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual interest expense?
- What is the all time high annual interest expense for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual interest expense year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly interest expense?
- What is the all time high quarterly interest expense for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly interest expense year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM interest expense?
- What is the all time high TTM interest expense for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM interest expense year-on-year change?
What is Takeda Pharmaceutical Company Limited annual interest expense?
The current annual interest expense of TAK is $1.52 B
What is the all time high annual interest expense for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual interest expense is $1.52 B
What is Takeda Pharmaceutical Company Limited annual interest expense year-on-year change?
Over the past year, TAK annual interest expense has changed by +$657.28 M (+75.88%)
What is Takeda Pharmaceutical Company Limited quarterly interest expense?
The current quarterly interest expense of TAK is $207.15 M
What is the all time high quarterly interest expense for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly interest expense is $649.27 M
What is Takeda Pharmaceutical Company Limited quarterly interest expense year-on-year change?
Over the past year, TAK quarterly interest expense has changed by -$253.71 M (-55.05%)
What is Takeda Pharmaceutical Company Limited TTM interest expense?
The current TTM interest expense of TAK is $692.95 M
What is the all time high TTM interest expense for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM interest expense is $1.87 B
What is Takeda Pharmaceutical Company Limited TTM interest expense year-on-year change?
Over the past year, TAK TTM interest expense has changed by -$243.69 M (-26.02%)